Decentralized Clinical Trials (DCTs) represent a paradigm shift in clinical research, moving away from the traditional hospital-centric model. By incorporating remote data collection, telehealth consultations, and home health visits, DCTs leverage technology to enhance flexibility and improve patient experience.

There is an urgent need for research into the relationship between LEMS and small cell lung cancer. Understanding this association can better facilitate advancements in medical research and treatments.